Contrarily, several studies demonstrated that patients treated with angiotensin-converting enzyme (ACE) inhibitors but not angiotensin receptor blocker (ARB) for more than 5 years have a higher lung cancer incidence (79). The gene discussed is ACE; the disease is lung cancer.